Hook
A decade ago, scientists proposed building a human genome from scratch. Today, the project is more relevant than ever for health optimization. Imagine a world where hereditary diseases are a thing of the past, where cells can be engineered to resist cancer and aging. That's the horizon painted by the Genome Project-write (GP-write), an initiative aiming to construct a complete human genome in the lab. While the path is long, advances in synthetic biology and plummeting costs make this dream increasingly tangible.
The Science
In 2016, the Genome Project-write (GP-write) launched with a bold goal: synthesize a complete human genome in the lab. Ten years later, the project continues, and its proponents argue it's worth pursuing. The aim isn't to replace humans but to understand genome design so well that we can create cells resistant to viruses, cancer, and aging. DNA synthesis has advanced dramatically: the cost per base pair has dropped from about $10 in 2000 to less than $0.01 today, making it economically feasible to synthesize a full genome, though a complete human genome hasn't been achieved yet.
The project leverages dramatic drops in DNA synthesis costs. While the original Human Genome Project cost ~$3 billion, synthesizing a genome today costs a fraction—though a full human genome hasn't been completed yet. Researchers have already synthesized bacterial and yeast genomes, proving the technology works. The key insight: by building a genome, we test which sequences are essential and which can be tweaked to enhance health. For instance, the synthetic yeast genome (Sc2.0) allowed scientists to rearrange genes and remove repetitive elements, demonstrating that life can function with a redesigned genome. This knowledge is directly applicable to the human genome.
